ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Blood Transfusion Devices Industry to 2026 - by Product, Blood Component, End-user and Region - ResearchAndMarkets.com

December 17, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Dec 17, 2021--

The “Global Blood Transfusion Devices Market, By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By Blood Component (Whole Blood, Plasma, RBC, Others), By End User, By Region, Forecast & Opportunities, 2026” report has been added to ResearchAndMarkets.com’s offering.

The global blood transfusion devices market is expected to grow at a CAGR of around 6% during the forecast period.

Companies Mentioned

  • Fresenius Kabi AG
  • Grifols SA
  • Terumo Corporation
  • B Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Immucor Inc
  • Haemonetics Corporation
  • Kaneka Corporation
  • Macopharma SA
  • Tenko International Group Corp

ADVERTISEMENT

The global blood transfusion devices market is driven by upsurge in count of surgical procedures being carried out across the globe. Moreover, developments in terms of technology is expected to positively impact the growth of the market during the forecast period. Also, rise in number of blood related disorders is further expected to bolster the growth of market over the next few years.

The global blood transfusion devices market is segmented based on product, type, blood component, end user, company, and region. Based on product, the market can be categorized into apheresis systems, infusion devices, blood warmers, venous access devices, filters, and others. Out of these, the apheresis systems segment dominated the market in terms of largest market share until 2020 and is expected to maintain leading position in the market during the forecast period as well. This can be ascribed to its wide use for the treatment of leukostasis, which is caused by increased white blood count in leukaemia. In addition to this, apheresis system is also used for treating severe rheumatoid arthritis, in order to minimize the risk associated with antibody-mediated rejection of organ during, systemic lupus, goodpasture syndrome, polymyositis or dermatomycosis, and preeclampsia and eclampsia during pregnancy, which is anticipated to boost the growth of the segment over the coming years.

ADVERTISEMENT

Major players operating in the global blood transfusion devices market include Fresenius Kabi AG, Grifols S.A., Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson, Company, Immucor Inc., Haemonetics Corporation, Kaneka Corporation, Macopharma SA, Tenko International Group Corp and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments.

Objective of the Study:

  • To analyze and estimate the market size of global blood transfusion devices market from 2016 to 2020.
  • To estimate and forecast the market size of global blood transfusion devices market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global blood transfusion devices market based on product, blood component, end user, company and regional distribution.
  • To identify dominant region or segment in the global blood transfusion devices market.
  • To identify drivers and challenges for global blood transfusion devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global blood transfusion devices market.
  • To conduct pricing analysis for global blood transfusion devices market.
  • To identify and analyze the profile of leading players operating in global blood transfusion devices market.
  • To identify key sustainable strategies adopted by market players in global blood transfusion devices market.

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Blood Transfusion Devices Market

4. Executive Summary

5. Voice of Customer

6. Global Blood Transfusion Devices Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)

6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)

6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)

6.2.4. By Company (2020)

6.2.5. By Region

6.3. Product Market Map

7. Asia-Pacific Blood Transfusion Devices Market Outlook

8. Europe Blood Transfusion Devices Market Outlook

9. North America Blood Transfusion Devices Market Outlook

10. South America Blood Transfusion Devices Market Outlook

11. Middle East and Africa Blood Transfusion Devices Market Outlook

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Competition Outlook

14.2. Company Profiles

15. Strategic Recommendations

16. About Us & Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/8z4rq

View source version on businesswire.com:https://www.businesswire.com/news/home/20211217005311/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 12/17/2021 09:10 AM/DISC: 12/17/2021 09:10 AM

http://www.businesswire.com/news/home/20211217005311/en